MedTrace Logo

Effects of BPA on Insulin and Glucose Responses

NCT03444922 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2019-02-18

No results posted yet for this study

Summary

The National Institutes of Health has encouraged research examining effects of BPA, yet evidence in humans evaluating the effects of BPA on insulin and glucose concentrations remains exclusively associative in nature. Thus, the primary purpose of this study is to determine whether an acute oral ingestion of BPA impacts insulin and glucose concentrations, and other endocrine factors (Pro-insulin, C-Peptide, Estrogen, triglycerides). Findings from this pilot study will inform public health recommendations for food packaging and provide much needed experimental evidence as to whether BPA poses any public health risk.

Conditions

  • Environmental Exposure

Interventions

OTHER

Placebo

Ingestion of Placebo

OTHER

BPA 4 ug/kg BW

Oral BPA ingestion of 4 ug/kg BW

OTHER

BPA 50 ug/kg BW

Oral BPA ingestion of 50 ug/kg BW

Sponsors & Collaborators

  • California Polytechnic State University-San Luis Obispo

    lead OTHER

Principal Investigators

  • Todd Hagobian, PhD · California Polytechnic State University-San Luis Obispo

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-09-01
Primary Completion
2019-02-14
Completion
2019-02-14

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03444922 on ClinicalTrials.gov